2021 AABB Annual Meeting On-Demand

Oct 17, 2021 ‐ Oct 19, 2021


Access to the 2021 AABB Annual Meeting On-Demand sessions expires on December 31, 2023. Each session includes the on-demand recording and a downloadable MP3 audio file. Closed captioning in Spanish and English also available for most sessions. Some speaker handouts may be available, but in general, presentation handouts are not available/included.



Sessions

AM21-11: El Desarrollo De Terapia Celular En Latino América (Cellular Therapy Development in Latin America)

Oct 17, 2021 3:45pm ‐ Oct 17, 2021 4:45pm

Credits: None available.

This educational session is a continuation of the topics presented in the CT Spanish sessions at the 2019 and 2020 AABB annual meetings. This time will focus on Latin America and its development in the field of CT. Initially the history of cell therapy in the world will be discussed with an emphasis on the introduction of this field in Latin American markets. These markets will be discussed by country, describe their development and acting position. Regulation of advanced therapy products in Latin America will also be discussed and barriers to the development of these therapies will be identified. The CT Spanish Subsection will utilize their monthly meetings as a platform to engage with AABB members and obtain up to date information related to their respective countries and their development. The results of our meetings & research, as well as the experiences shared by the speakers will be presented. This will only be in Spanish.

Esta sesión educativa es una continuación de los temas presentados en las sesiones de Terapia Celular (TC) sección en Español en las reuniones anuales de la AABB de los años 2019 y 2020. Esta vez se centrará en América Latina y su desarrollo en el campo de la TC. Inicialmente la historia de la TC en el mundo se discutirá con énfasis en la introducción de este campo en los mercados latinoamericanos. Estos mercados serán discutidos por país, describirán su desarrollo y posición de actual. También se discutirá la regulación de estos productos en América Latina y se identificarán barreras para el desarrollo de estas terapias. La Subsección de Terapia Celular en Español de utilizará sus reuniones mensuales como plataforma para interactuar con los miembros de la AABB y obtener información actualizada relacionada con sus respectivos países y su desarrollo. Se presentarán los resultados de nuestros encuentros e investigaciones, así como las experiencias compartidas por los ponentes. Esta sesión se celebrará en su totalidad en el idioma español.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Review the historical background of some countries that use cell therapy. (Revisar los antecedentes históricos de algunos países que utilizan terapia celular).
  • Identify which areas of cell therapy the Latin American countries focus on their development. (Identificar qué áreas de terapia celular los países latinoamericanos enfocan su desarrollo).
  • Compare the differences in regulations between different countries. (Comparar las diferencias en las regulaciones entre diferentes países).
  • Describe the benefits of AABB membership for process improvement in cell therapy. (Describir los beneficios de la membresía de la AABB para mejora de procesos en terapia celular).
Moderator(s): Speaker(s): Disclosures
  • Federico Rodriguez Quezada, SBB, MLS(ASCP) : Nothing to Disclose
  • Carlos Ferrari, MT : Nothing to Disclose
  • Maria de los Angeles Muñiz, M.D. : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-12: Blood Banking and Transfusion Medicine Fundamentals II: Immunohematology Methods and Blood Groups

Oct 17, 2021 2:30pm ‐ Oct 17, 2021 3:30pm

Credits: None available.

Session 2 of Blood Bank Fundamentals will explore serologic testing and blood groups.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Explain the American Society of Clinical Pathologist (ASCP) SBB and BB exam requirements
  • Review and explain the topics outlined on the ASCP BB/SBB Exam Content Outline
  • Define and relate pertinent information from the ASCP Content Outline that will be on these exams to aid in preparing for the BB or SBB exam.
  • Discover helpful hints for studying for and taking these exams.
  • Apply knowledge for interactive question and answer polling session.
Moderator(s): Speaker(s): Disclosures
  • Michelle Lodermeier, MBA, MLS(ASCP)SBB : Nothing to Disclose
  • Paul Mansfield, MT(ASCP), SBB : Nothing to Disclose
  • Jayanna Slayten, MS, MT(ASCP)SBB : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-13: Therapeutic Phlebotomy - Providing a Simple and Effective Treatment

Oct 17, 2021 6:00pm ‐ Oct 17, 2021 7:00pm

Credits: None available.

Phlebotomy is an ancient medical procedure that has been performed for thousands of years. In the 20th century, evidence supporting the use of therapeutic phlebotomy (TP) in conditions such as including hereditary hemochromatosis, polycythemia vera, and secondary iron overload became available. Despite the widespread use, TP is sometimes viewed as an orphan procedure because there is lack of standardization in how, where, and by whom the procedure is performed. This session will review complications of iron overload, indications for TP, and complications/adverse events associated with TP. Potential billing challenges will be identified and addressed. Pediatric considerations will be explored, including necessary vascular access, and relative rates of iron removal in growing patients. Finally, a blood center’s perspective on optimizing their adult TP program will be explored.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Discuss the role of transfusion medicine physicians in the performance of therapeutic phlebotomy procedures.
  • Review best practices for performance of therapeutic phlebotomy in patients with small blood volumes.
  • Summarize challenges and opportunities associated with a community blood center therapeutic phlebotomy program.
  • Identify indications for therapeutic phlebotoby (TP) and the long-term complications of iron overload.
Moderator(s): Speaker(s): Disclosures
  • Catherine Mazzei : Nothing to Disclose
  • Jennifer Webb, MD, MSCE : Nothing to Disclose
  • Alexis Peedin, MD : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-14: Evolving Use of Rh Antigen Genotyping for Improved Red Cell Transfusion Matching

Oct 17, 2021 6:00pm ‐ Oct 17, 2021 7:00pm

Credits: None available.

Alloimmunization to non-ABO antigens is one of the most common complications of blood transfusions. Blood group antigen profiling and prophylactic antigen matching have reduced but not eliminated alloimmunization. DNA-based genotyping methods enable accurate prediction of most blood group antigen phenotypes. Compared to traditional serologic typing, genotyping is particularly useful for patients with recent transfusion or to identify low frequency antigens for which serologic reagents are not available. Genotyping can also identify variant RH alleles that are common in patients with sickle cell disease, allowing more precise matching between patients and blood donors. In this session, we will review the challenges for blood group antigen genotyping focusing on Rh antigens, and discuss strategies to incorporate genotyping results to improve red cell matching and prevent alloimmunization.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Discuss the advantages of blood group antigen genotyping
  • Discuss approaches for RH genotyping, including whole genome sequencing.
  • Discuss strategies to apply blood group antigen genotyping to improve red cell matching.
Moderator(s): Speaker(s): Disclosures
  • Stella Chou, MD : Consultant: PlateletBio
  • Connie Westhoff, SBB, PhD : Nothing to Disclose
  • Yan Zheng : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-15: Pediatric Cellular Therapy: An Overview from Collections to Alpha/Beta Depletions

Oct 17, 2021 6:00pm ‐ Oct 17, 2021 7:00pm

Credits: None available.

Pediatric advanced therapies are an exciting, complex and evolving field. Autologous collections require collaboration between flexible apheresis services and the clinical/research team for success, including quality and reducing error. Mobilization, collection and processing methods impact the final therapeutic product. For haploidentical hematopoietic cell transplantation, Alpha/Beta T-cell Depletion has transformed the approach to donor selection and significantly expanded availability. A modern approach is sophisticated ex vivo processing of the donor graft to remove those cells most responsible for causing GVHD. This session will present examples and discuss the ongoing therapeutic diversification and development in cellular therapy protocols, which will require international collaboration to improve standardization, efficiency, and quality.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Describe the range of pediatric advanced therapies for which apheresis cell collections are undertaken
  • Identify issues which add to the complexity of the process for apheresis teams and which could be improved by international collaboration.
  • Describe how Alpha/Beta T-cell Depletion is performed
  • Contrast the pros/cons of in vivo and ex vivo T-cell depletion strategies in pediatric patients undergoing haploidentical HCT
Moderator(s): Speaker(s): Disclosures
  • Kyle Annen, DO : Consultant: Terumo BCT
  • Christopher Dvorak, MD : Nothing to Disclose
  • Helen New : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-16: Blood Banking and Transfusion Medicine Fundamentals III: Transfusion Medicine Physiology and Pathophysiology

Oct 17, 2021 3:45pm ‐ Oct 17, 2021 4:45pm

Credits: None available.

Session 3 of Blood Bank Fundamentals will apply serologic testing and transfusion practice to challenging patient scenarios.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Explain the American Society of Clinical Pathologist (ASCP) SBB and BB exam requirements
  • Review and explain the topics outlined on the ASCP BB/SBB Exam Content Outline
  • Define and relate pertinent information from the ASCP Content Outline that will be on these exams to aid in preparing for the BB or SBB exam.
  • Discover helpful hints for studying for and taking these exams.
  • Apply knowledge for interactive question and answer polling session.
Moderator & Speaker(s): Speaker(s): Disclosures
  • Jayanna Slayten, MS, MT(ASCP)SBB : Nothing to Disclose
  • Lorraine Blagg, MA, MLS(ASCP)SBB : Nothing to Disclose
  • Natasha Leon, MT(ASCP)SBB : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-18: Quality Essentials for Blood Banks/Transfusion Services and Blood Centers

Oct 17, 2021 7:15pm ‐ Oct 17, 2021 8:15pm

Credits: None available.

According to the Institute of Medicine (IOM) report, To Err Is Human, the majority of medical errors result from faulty systems and processes, not individuals. Because errors are caused by system or process failures, it is important to adopt various process-improvement techniques to identify inefficiencies and preventable errors to then influence changes associated with systems. The seven basic quality tools and strategies for quality improvement include cause-and-effect diagram, check sheet, control chart, histogram, pareto chart, flowchart and 5 whys.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Describe the 7 basic quality tools used for quality improvement and patient/donor safety initiatives.
  • Use quality tools at a hospital-based Transfusion Service and donor centers to detect and prevent the reoccurrence of a patient-safety related Biological Product Deviation event.
  • Apply quality tools to case scenarios to produce corrective actions, process improvement and follow-up audits for more efficient processes.
Moderator(s):
  • Tracie Nichols, MS, MLS(ASCP), SBB, Technical Specialist, Accreditation and Quality, AABB
Speaker(s): Disclosures
  • Tracie Nichols, MS, MLS(ASCP), SBB : Nothing to Disclose
  • Vaanush Nazaryan, MBA, SBB(ASCP), CPHQ : Nothing to Disclose
  • Susan Wilson, MLS(ASCP)SBB : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-19: Informatics Tools for Transfusion Support of Hematopoietic Progenitor Cell Transplant Recipients

Oct 17, 2021 7:15pm ‐ Oct 17, 2021 8:15pm

Credits: None available.

This session will illustrate how to leverage lab information system (LIS) and electronic health record (EHR) tools for communication and control of hematopoietic progenitor cell transplant (HPCT) recipient transfusion needs and will be applicable to multiple lab information and electronic health record systems. The session will also include an introduction to transfusion support for HPCT recipients. Examples of EHR designs will demonstrate how to streamline blood ordering processes to limit frequent addition or removal of special attributes and communicate transfusion needs. We will also present LIS-based solutions to hardwire selection of red blood cell and plasma-containing products based on donor and recipient ABO types and allow for safe electronic crossmatch. Potential software limitations will also be discussed.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Discuss transfusion support needs for patients receiving ABO-incompatible hematopoietic progenitor cell transplant
  • Design IT-based solutions to prevent inappropriate blood product selection in setting of ABO-incompatible transplant
  • Propose IT-based processes for communication of appropriate blood product attributes including special requirements and ABO compatibility for patients receiving hematopoietic progenitor cell transplantation
Moderator(s): Speaker(s): Disclosures
  • Nabiha Saifee, MD, PhD : Nothing to Disclose
  • Kris Guido, MT (ASCP) : Nothing to Disclose
  • Ronald Jackups, MD, PhD : Consultant: Instrumentation Laboratory; Unrestricted educational grant via Wiley: BioRad
Members: $20.00
Standard: $25.00

AM21-20: Blood Bank and Transfusion Medicine Fundamentals IV: Donor Collection, Blood Products, Laboratory Management and Blood Bank Quality

Oct 17, 2021 6:00pm ‐ Oct 17, 2021 7:00pm

Credits: None available.

This last session of Blood Bank Fundamentals will define and apply blood center details, quality/lab operations and management, then close with a review of what to expect for the BB and SBB exams.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Explain the American Society of Clinical Pathologist (ASCP) SBB and BB exam requirements
  • Review and explain the topics outlined on the ASCP BB/SBB Exam Content Outline
  • Define and relate pertinent information from the ASCP Content Outline that will be on these exams to aid in preparing for the BB or SBB exam.
  • Discover helpful hints for studying for and taking these exams.
  • Apply knowledge for interactive question and answer polling session.
Moderator & Speaker(s): Speaker(s): Disclosures
  • Jayanna Slayten, MS, MT(ASCP)SBB : Nothing to Disclose
  • Traci Paige, MT(ASCP)SBBcm : Nothing to Disclose
  • Wyenona Hicks, MS, MT(ASCP) SBB : Nothing to Disclose
Members: $20.00
Standard: $25.00

AM21-21: Challenges and Triumphs from the Implementation of Major Donor Eligibility Changes during a Global Pandemic

Oct 18, 2021 10:00am ‐ Oct 18, 2021 11:00am

Credits: None available.

The COVID-19 pandemic created unprecedented challenges to meet blood supply demands, thus resulting in significant blood shortages. As a means to mitigate shortages, the FDA released revised guidance for HIV, malaria, and vCJD that contained numerous recommendations for changes in donor deferral. These recommendations required the development and release of the Donor History Questionnaire (DHQ) v2.1. Even under normal circumstances, implementation of major donor deferral changes requires significant time and resources. This was exacerbated by the pandemic. In this session, the AABB Donor History Task Force and others will present the following:

  • An overview of resources to aid in implementation of the Donor History Questionnaire (DHQ)
  • Data collected through surveys and focus groups detailing challenges and successes in implementing the DHQ v2.1 during the COVID-19 pandemic
  • First-hand experience from a blood center in overcoming challenges and finding opportunities during the pandemic

To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Identify what resources and tools are available to aid in the implementation of changes to the Donor History Questionnaire (DHQ).
  • Describe common challenges, successes and opportunities for improvement in implementing a DHQ during the pandemic.
  • Utilize lessons learned and first-hand experience from other centers on how overcome these challenges.
Moderator(s): Speaker(s): Disclosures
  • Lucette Hall, BS, MBA : Nothing to Disclose
  • Geoffrey Belanger, MPH : Nothing to Disclose
  • Jessie Singer, MT(ASCP)SBB : Nothing to Disclose
Members: $20.00
Standard: $25.00